Indian markets remain near record highs, but a sharp rupee fall and global volatility have raised red flags, says market expert Ajay Bagga. He warns that RBI’s absence during the currency slide could hurt FPI sentiment and delay rate cuts. A US–India trade deal remains the biggest potential trigger, while private-sector banks continue to look attractive
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,
June 1, 2026